Nonpeptidyl somatostatin agonists demonstrate that sst2 and sst5 inhibit stimulated growth hormone secretion from rat anterior pituitary cells

被引:42
作者
Parmar, RM [1 ]
Chan, WWS [1 ]
Dashkevicz, M [1 ]
Hayes, EC [1 ]
Rohrer, SP [1 ]
Smith, RG [1 ]
Schaeffer, JM [1 ]
Blake, AD [1 ]
机构
[1] Merck Res Labs, Rahway, NJ 07065 USA
关键词
somatostatin; growth hormone; secretion; receptor subtypes;
D O I
10.1006/bbrc.1999.1376
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Somatostatin (SST) regulates growth hormone (GH) secretion from pituitary somatotrophs by interacting with members of the SST family of G-protein-coupled receptors (sst1-5). We have used potent, nonpeptidyl SST agonists with sst2 and sst5 selectivity to-determine whether these receptor subtypes are involved in regulating growth hormone releasing hormone (GHRH) stimulated secretion. GHRH stimulated GH release from pituitary cells in a dose-dependent manner, and this secretion was inhibited by Tyr(11)-SST-14, a nonselective SST analog. A sst2 selective agonist, L-779,976, potently inhibited GHRH-stimulated GH release. In addition, L-817,818, a potent sst5 receptor selective agonist, also inhibited GH secretion, but was approximately 10-fold less potent (P < 0.01, ANOVA) in inhibiting GH release than either Tyr(11)-SST-14 or L-779,976. These results show that both sst2 and sst5 receptor subtypes regulate GHRH-stimulated GH release from rat pituitary cells. (C) 1999 Academic Press.
引用
收藏
页码:276 / 280
页数:5
相关论文
共 36 条
[1]   Discovery of a novel non-peptide somatostatin agonist with SST4 selectivity [J].
Ankersen, M ;
Crider, M ;
Liu, SQ ;
Ho, B ;
Andersen, HS ;
Stidsen, C .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1998, 120 (07) :1368-1373
[2]   HYPOTHALAMIC POLYPEPTIDE THAT INHIBITS SECRETION OF IMMUNOREACTIVE PITUITARY GROWTH-HORMONE [J].
BRAZEAU, P ;
VALE, W ;
BURGUS, R ;
LING, N ;
BUTCHER, M ;
RIVIER, J ;
GUILLEMIN, R .
SCIENCE, 1973, 179 (4068) :77-79
[3]  
BREDER CD, 1992, J NEUROSCI, V12, P3920
[4]   SOMATOSTATIN - ANALOGS WITH SELECTED BIOLOGICAL-ACTIVITIES [J].
BROWN, M ;
RIVIER, J ;
VALE, W .
SCIENCE, 1977, 196 (4297) :1467-1469
[5]  
CHENG K, 1989, ENDOCRINOLOGY, V124, P2791
[6]   EXPRESSION OF MESSENGER-RNA FOR SOMATOSTATIN RECEPTOR (SSTR) TYPE-2 AND TYPE-5 IN INDIVIDUAL, RAT PITUITARY-CELLS - A DOUBLE-LABELING IN-SITU HYBRIDIZATION ANALYSIS [J].
DAY, R ;
DONG, WJ ;
PANETTA, R ;
KRAICER, J ;
GREENWOOD, MT ;
PATEL, YC .
ENDOCRINOLOGY, 1995, 136 (11) :5232-5235
[7]   Multiple intracellular effectors modulate physiological functions of the cloned somatostatin receptors [J].
Florio, T ;
Schettini, G .
JOURNAL OF MOLECULAR ENDOCRINOLOGY, 1996, 17 (02) :89-100
[8]  
FROHMAN LA, 1992, FRONT NEUROENDOCRIN, V13, P344
[9]   SOMATOSTATIN RECEPTOR SUBTYPE SSTR2 MEDIATES THE INHIBITION OF HIGH-VOLTAGE-ACTIVATED CALCIUM CHANNELS BY SOMATOSTATIN AND ITS ANALOG SMS-201-995 [J].
FUJII, Y ;
GONOI, T ;
YAMADA, Y ;
CHIHARA, K ;
INAGAKI, N ;
SEINO, S .
FEBS LETTERS, 1994, 355 (02) :117-120
[10]   A backbone-cylic, receptor 5-selective somatostatin analogue:: Synthesis, bioactivity, and nuclear magnetic resonance conformational analysis [J].
Gilon, C ;
Huenges, M ;
Mathä, B ;
Gellerman, G ;
Hornik, V ;
Afargan, M ;
Amitay, O ;
Ziv, O ;
Feller, E ;
Gamliel, A ;
Shohat, D ;
Wanger, M ;
Arad, O ;
Kessler, H .
JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (06) :919-929